Abstract
The aim of this study is to try to develop an RNA interference (RNAi) approach to human cytomegalovirus (HCMV) therapy by inhibition of viral DNA polymerase (product of the UL54 gene) expression in vitro. The fusion protein expression plasmid pEGFP-UL54 was constructed and cotransfected into AD293 cells with the lentiviral vector pGCL-GFP expressing small hairpin RNA (shRNA) especially targeting the UL54 gene. At 24, 48, and 72 h posttransfection, expression of the fusion protein was detected by fluorescence microscopy and Western blot. The level of UL54 mRNA was semiquantitated by reverse transcription polymerase chain reaction. It was found that, compared with the negative control, expression of the EGFP-UL54 fusion protein was efficiently inhibited and the mRNA level of the UL54 gene decreased significantly in cells introduced with a shRNA producing plasmid called pGCL-UL54-1479. However, the plasmid pGCL-UL54-2884 had no significant inhibitive effect on protein expression or mRNA level. It may be concluded that introduction of shRNA targeting UL54 gene of HCMV could specifically inhibit the expression of viral DNA polymerase in vitro. Nucleotides 1479-1499 of the UL54 gene seems to be an effective target site of RNAi.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agrawal N, Dasaradhi PV, Mohmmed A et al (2003) RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev 67:657–685
Chou S, Lurain NS, Weinberg A et al (1999) Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. Antimicrob Agents Chemother 43:1500–1502
Choudhary S, Lee HC, Maiti M et al (2007) A double-stranded-RNA response program important for RNA interference efficiency. Mol Cell Biol 27:3995–4005
Coburn GA, Cullen BR (2002) Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 76:9225–9231
Henriksen JR, Løkke C, Hammerø M et al (2007) Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines. Nucleic Acids Res 35:e67
Kretschmer-Kazemi Far R, Sczakiel G (2003) The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res 31:4417–4424
Landolfo S, Gariglio M, Gribaudo G et al (2003) The human cytomegalovirus. Pharmacol Ther 98:269–297
Limaye AP, Corey L, Koelle DM et al (2000) Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 356:645–649
McManus MT, Sharp PA (2002) Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3:737–747
Milhavet O, Gary DS, Mattson MP (2003) RNA interference in biology and medicine. Pharmacol Rev 55:629–648
Morris KV, Rossi JJ (2006) Lentiviral-mediated delivery of siRNAs for antiviral therapy. Gene Ther 13:553–558
Nogueira E, Ozaki KS, Tomiyama H et al (2006) The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Int Immunopharmacol 6:2031–2037
Oberdoerffer P, Kanellopoulou C, Heissmeyer V et al (2005) Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages. Mol Cell Biol 25:3896–3905
Palliser D, Chowdhury D, Wang QY et al (2006) An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439:89–94
Pass RF (2007) Congenital cytomegalovirus infection: impairment and immunization. J Infect Dis 195:767–769
Pyrc K, Bosch BJ, Berkhout B et al (2006) Inhibition of human coronavirus NL63 infection at early stages of the replication cycle. Antimicrob Agents Chemother 50:2000–2008
Scott GM, Isaacs MA, Zeng F et al (2004) Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations. J Med Virol 74:85–93
Scott GM, Weinberg A, Rawlinson WD et al (2007) Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates. Antimicrob Agents Chemother 51:89–94
Seibler J, Küter-Luks B, Kern H et al (2005) Single copy shRNA configuration for ubiquitous gene knockdown in mice. Nucleic Acids Res 33:e67
Shin MC, Hong SK, Yoon JS et al (2006) Inhibition of UL54 and UL97 genes of human cytomegalovirus by RNA interference. Acta Virol 50:263–268
Uprichard SL, Boyd B, Althage A et al (2005) Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci USA 102:773–778
van der Sande MA, Kaye S, Miles DJ et al (2007) Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS ONE 2:e492
Wiebusch L, Truss M, Hagemeier C (2004) Inhibition of human cytomegalovirus replication by small interfering RNAs. J Gen Virol 85:179–184
Xia XG, Zhou H, Ding H et al (2003) An enhanced U6 promoter for synthesis of short hairpin RNA. Nucleic Acids Res 31:e100
Yu JY, DeRuiter SL, Turner DL (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 99:6047–6052
Acknowledgment
This work was supported by a grant from the National Natural Science Foundation of China (No. 30571663).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tao, R., Hu, M., Duan, Q. et al. Efficient Inhibition of Human Cytomegalovirus DNA Polymerase Expression by Small Hairpin RNA In Vitro. Curr Microbiol 57, 395–400 (2008). https://doi.org/10.1007/s00284-008-9210-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-008-9210-0